SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Avraham Pharmaceuticals Ltd. Receives Orphan Medicinal Product Designation for Tivozanib for the Treatment of Renal Cell Carcinoma by the European Medicines Evaluation Agency